Gentium: The Best-Performing Biotechs of 2013

With the Nasdaq Biotechnology Index up 65% since the start of the year, it's clear that the biotech sector performed extraordinarily well in 2013 -- but which stocks were the biggest winners? Several small-cap and mid-cap biotech companies posted returns of 200% or more through the middle of December this year, and, in this series, I review the 15 ... (more)

http://www.fool.com/investing/general/2014/01/02/gentium-the-best-performing-biotechs-of-2013.aspx